Blocking Thrombospondin-1/CD47 Signaling Alleviates Deleterious Effects of Aging on Tissue Responses to Ischemia
- 1 December 2007
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 27 (12), 2582-2588
- https://doi.org/10.1161/atvbaha.107.155390
Abstract
Objective— Decreased blood flow secondary to peripheral vascular disease underlies a significant number of chronic diseases that account for the majority of morbidity and mortality among the elderly. Blood vessel diameter and blood flow are limited by the matricellular protein thrombospondin-1 (TSP1) through its ability to block responses to the endogenous vasodilator nitric oxide (NO). In this study we investigate the role TSP1 plays in regulating blood flow in the presence of advanced age and atherosclerotic vascular disease. Methods and Results— Mice lacking TSP1 or CD47 show minimal loss of their resistance to ischemic injury with age and increased preservation of tissue perfusion immediately after injury. Treatment of WT and apolipoprotein E–null mice using therapeutic agents that decrease CD47 or enhance NO levels reverses the deleterious effects of age- and diet-induced vasculopathy and results in significantly increased tissue survival in models of ischemia. Conclusion— With increasing age and diet-induced atherosclerotic vascular disease, TSP1 and its receptor CD47 become more limiting for blood flow and tissue survival after ischemic injury. Drugs that limit TSP1/CD47 regulation of blood flow could improve outcomes from surgical interventions in the elderly and ameliorate vascular complications attendant to aging.Keywords
This publication has 31 references indexed in Scilit:
- Increasing Survival of Ischemic Tissue by Targeting CD47Circulation Research, 2007
- Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide–mediated vascular smooth muscle relaxationBlood, 2006
- Age-Dependent Acceleration of Ischemic Injury in Endothelial Nitric Oxide Synthase-Deficient Mice: Potential Role of Impaired VEGF Receptor 2 ExpressionJournal of Cardiovascular Pharmacology, 2006
- Thrombospondin 1, thrombospondin 2 and the eyeProgress in Retinal and Eye Research, 2006
- Calcifications, Arterial Stiffness and AtherosclerosisPublished by S. Karger AG ,2006
- Differential expression of EDF-1 and endothelial nitric oxide synthase by proliferating, quiescent and senescent microvascular endothelial cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2005
- Critical overexpression of thrombospondin 1 in chronic leg ischaemiaThe Journal of Pathology, 2005
- Risk Factors for Delayed Healing and Recurrence of Chronic Venous Leg Ulcers—An Analysis of 1324 LegsEuropean Journal of Vascular and Endovascular Surgery, 2005
- Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia.JCI Insight, 1998
- Thrombospondin modulates alpha v beta 3 function through integrin-associated protein.The Journal of cell biology, 1996